Apogee Therapeutics, Inc. (APGE)
$135.02+$0.06 (+0.04%) Today
Carl Dambkowski - Officer
Michael Thomas Henderson - OfficerCarl Dambkowski - OfficerCarl Dambkowski - OfficerMichael Thomas Henderson - OfficerMichael Thomas Henderson - OfficerMichael Thomas Henderson - OfficerMichael Thomas Henderson - OfficerApogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
https://www.apogeetherapeutics.comSEC filings for APGE on EDGAR
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 12 | 162,900 | $20.34M |
| Grant or award | 6 | 45,942 | |
| Option exercise | 10 | 109,166 | |
| Bona-fide gift | 3 | 98,046 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
57 Form 4 filings on record, the earliest from Oct 4, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Jane Henderson - Officer | Open-market sale | Common Stock | 792 | $65.21 | $52K | |
| Jane Henderson - Officer | Open-market sale | Common Stock | 100 | $66.89 | $7K | |
| Jane Henderson - Officer | Open-market sale | Common Stock | 1,108 | $66.15 | $73K | |
| Fairmount Funds Management LLC - Director | Open-market sale | Common Stock | 1,750,000 | $76.30 | $133.53M | |
| Michael Thomas Henderson - Officer | Open-market sale | Common Stock | 1,440 | $78.64 | $113K | |
| Michael Thomas Henderson - Officer | Open-market sale | Common Stock | 8,476 | $79.82 | $677K | |
| Michael Thomas Henderson - Officer | Open-market sale | Common Stock | 2,374 | $81.00 | $192K | |
| Michael Thomas Henderson - Officer | Open-market sale | Common Stock | 1,854 | $82.41 | $153K | |
| Michael Thomas Henderson - Officer | Open-market sale | Common Stock | 5,386 | $83.16 | $448K | |
| Michael Thomas Henderson - Officer | Open-market sale | Common Stock | 470 | $83.79 | $39K | |
| Carl Dambkowski - Officer | Open-market sale | Common Stock | 10,900 | $75.00 | $818K | |
| Michael Thomas Henderson - Officer | Open-market sale | Common Stock | 40,000 | $75.01 | $3.00M | |
| Jane Henderson - Officer | Open-market sale | Common Stock | 1,500 | $75.00 | $113K | |
| Jane Henderson - Officer | Open-market sale | Common Stock | 1,500 | $70.00 | $105K | |
| Jane Henderson - Officer | Open-market sale | Common Stock | 2,000 | $65.00 | $130K | |
| Jane Henderson - Officer | Open-market sale | Common Stock | 1,000 | $60.00 | $60K | |
| Michael Thomas Henderson - Officer | Open-market sale | Common Stock | 1,786 | $63.89 | $114K | |
| Michael Thomas Henderson - Officer | Open-market sale | Common Stock | 100 | $64.52 | $6K | |
| Michael Thomas Henderson - Officer | Open-market sale | Common Stock | 3,340 | $61.93 | $207K | |
| Michael Thomas Henderson - Officer | Open-market sale | Common Stock | 14,774 | $63.14 | $933K | |
| Carl Dambkowski - Officer | Open-market sale | Common Stock | 5,607 | $55.58 | $312K | |
| Carl Dambkowski - Officer | Open-market sale | Common Stock | 678 | $56.51 | $38K | |
| Carl Dambkowski - Officer | Option exercise | Stock Option (Right to Buy) | 8,060 | $0.00 | - | |
| Carl Dambkowski - Officer | Option exercise | Common Stock | 8,060 | $22.86 | $184K | |
| Carl Dambkowski - Officer | Open-market sale | Common Stock | 2,300 | $53.62 | $123K | |
| Carl Dambkowski - Officer | Open-market sale | Common Stock | 2,200 | $54.83 | $121K | |
| Nimish P. Shah | Open-market purchase | Pre-Funded Warrants (Right to Buy) | 365,853 | $41.00 | $15.00M | |
| Carl Dambkowski - Officer | Option exercise | Common Stock | 2,385 | $22.86 | $55K | |
| Carl Dambkowski - Officer | Open-market sale | Common Stock | 5,110 | $39.80 | $203K | |
| Carl Dambkowski - Officer | Option exercise | Stock Option (Right to Buy) | 2,385 | $0.00 | - | |
| Carl Dambkowski - Officer | Open-market sale | Common Stock | 2,535 | $37.82 | $96K | |
| Carl Dambkowski - Officer | Open-market sale | Common Stock | 190 | $38.55 | $7K | |
| Carl Dambkowski - Officer | Open-market sale | Common Stock | 2,725 | $37.78 | $103K | |
| Carl Dambkowski - Officer | Option exercise | Common Stock | 7,365 | $22.86 | $168K | |
| Carl Dambkowski - Officer | Open-market sale | Common Stock | 6,409 | $44.77 | $287K | |
| Carl Dambkowski - Officer | Open-market sale | Common Stock | 2,935 | $45.49 | $134K | |
| Carl Dambkowski - Officer | Open-market sale | Common Stock | 746 | $46.26 | $35K | |
| Carl Dambkowski - Officer | Option exercise | Stock Option (Right to Buy) | 7,365 | $0.00 | - | |
| Mark C. McKenna - Director | Open-market purchase | Common Stock | 7,500 | $49.02 | $368K | |
| Mark C. McKenna - Director | Open-market purchase | Common Stock | 12,500 | $49.85 | $623K | |
| Carl Dambkowski - Officer | Option exercise | Common Stock | 1,815 | $22.86 | $41K | |
| Carl Dambkowski - Officer | Open-market sale | Common Stock | 4,085 | $48.62 | $199K | |
| Carl Dambkowski - Officer | Open-market sale | Common Stock | 455 | $50.00 | $23K | |
| Carl Dambkowski - Officer | Option exercise | Stock Option (Right to Buy) | 1,815 | $0.00 | - | |
| Michael Thomas Henderson - Officer | Grant or award | Stock Option (Right to Buy) | 357,036 | $0.00 | - | |
| Jane Henderson - Officer | Grant or award | Stock Option (Right to Buy) | 124,962 | $0.00 | - | |
| Carl Dambkowski - Officer | Grant or award | Stock Option (Right to Buy) | 124,962 | $0.00 | - | |
| Michael Thomas Henderson - Officer | Open-market sale | Common Stock | 13,328 | $46.50 | $620K | |
| Michael Thomas Henderson - Officer | Open-market sale | Common Stock | 1,672 | $47.19 | $79K | |
| Carl Dambkowski - Officer | Open-market sale | Common Stock | 6,665 | $46.07 | $307K | |
| Carl Dambkowski - Officer | Open-market sale | Common Stock | 5,326 | $58.91 | $314K | |
| Carl Dambkowski - Officer | Open-market sale | Common Stock | 1,339 | $59.96 | $80K | |
| Michael Thomas Henderson - Officer | Open-market sale | Common Stock | 14,000 | $59.17 | $828K | |
| Michael Thomas Henderson - Officer | Open-market sale | Common Stock | 1,000 | $59.94 | $60K | |
| Michael Thomas Henderson - Officer | Open-market sale | Common Stock | 30,288 | $56.07 | $1.70M | |
| Michael Thomas Henderson - Officer | Open-market sale | Common Stock | 9,712 | $56.74 | $551K | |
| Carl Dambkowski - Officer | Open-market sale | Common Stock | 5,740 | $56.16 | $322K | |
| Carl Dambkowski - Officer | Open-market sale | Common Stock | 925 | $56.86 | $53K |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR |
Apogee Therapeutics, Inc. (APGE) had 16 insider filings in the last 90 days, with the most recent on 2026-08-11. The full record for APGE runs to 57 Form 4 filings, the earliest from 2024-10-04. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of APGE were filed in the last 90 days. 3 purchases are on record for this company.
12 insider sales of APGE were filed in the last 90 days, totaling $20.34M.
This page tracks APGE Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add APGE to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
